Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multidrug resistance in acute leukemia].

N Nara

    [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
    |March 1, 1989
    PubMed
    Summary

    Most leukemia patients relapse and die from recurrent or refractory disease. This review covers understanding drug resistance in leukemia and clinical strategies to overcome it, focusing on P-glycoprotein.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prognostic implications of blast self-renewal capacity in acute myelocytic-leukemia.

    International journal of oncology·2011
    Same author

    Relation of protein kinase A and protein kinase C to signaling pathways of hematopoietic factors in leukemia cell lines.

    International journal of oncology·2011
    Same author

    Phosphorylation of signaling proteins in factor-independent myeloid leukemia cell lines.

    International journal of oncology·2011
    Same author

    Effect of continuous intravenous administration of high-dose G-CSF on hematologic recovery following autologous purged bone marrow transplantation.

    International journal of oncology·2011
    Same author

    Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells.

    Leukemia & lymphoma·2001
    Same author

    Human herpesvirus 8 DNA in HIV-negative Japanese patients with multicentric Castleman's disease and related diseases.

    International journal of molecular medicine·2001

    Area of Science:

    • Hematology
    • Oncology
    • Pharmacology

    Background:

    • Leukemia treatment advances have not eliminated patient relapse and mortality from refractory disease.
    • Addressing recurrent or refractory leukemia and overcoming drug resistance are critical clinical challenges.
    • Multidrug resistance in tumor cells, particularly involving P-glycoprotein, is a key area of research.

    Purpose of the Study:

    • To review recent advances in understanding the pathophysiology of drug resistance in leukemic cells.
    • To discuss current clinical approaches for treating drug-resistant leukemia.

    Main Methods:

    • Literature review of recent scientific advances.
    • Analysis of the role of P-glycoprotein in multidrug resistance.
    • Discussion of clinical strategies for drug-resistant leukemia.

    Main Results:

    • Leukemic cell drug resistance, mediated by factors like P-glycoprotein, contributes to treatment failure.
    • Understanding the mechanisms of resistance is crucial for developing effective therapies.
    • Various clinical approaches are being explored to combat drug-resistant leukemia.

    Conclusions:

    • Further research into the pathophysiology of drug resistance is needed.
    • Developing novel therapeutic strategies to overcome multidrug resistance is essential for improving leukemia patient outcomes.
    • Clinical management of relapsed and refractory leukemia requires addressing drug resistance mechanisms.

    Related Experiment Videos